Cambridge Public Health Commission

Cambridge Public Health Commission, doing business as Cambridge Health Alliance, is a tax-exempt public hospital system and non-profit health organization based in Cambridge, Massachusetts that receives federal grant funding primarily as a prime recipient in behavioral health research, mental health services, and public health programs. The organization does not hold federal contracts but serves as both a prime grant recipient and a subrecipient on research awards from the National Institutes of Health, the Substance Abuse and Mental Health Services Administration, and the Federal Emergency Management Agency.

Cambridge Health Alliance's federal footprint is concentrated in biomedical and behavioral health research and community mental health service delivery. As a prime recipient, the organization holds grants for substance-use epidemiology research funded by the National Institute on Drug Abuse—including a $776,604 project grant beginning June 2026 examining the impact of recreational cannabis legalization on cannabis, nicotine, and alcohol use patterns among adolescents and young adults with mental illness (CFDA 93.279), and a project grant awarded December 2024 studying the effects of cannabis commercialization on substance use and mental health outcomes in psychotic disorders. CHA also holds a $1,238,703 Assistance to Firefighters Grant from FEMA (CFDA 97.044) that ran September 2021 through September 2024, supporting fire safety and firefighter health programs. In community mental health service delivery, CHA received a project grant from SAMHSA's Center for Mental Health Services in September 2024 for the Family Connections system-of-care program—a community-based approach to expanding mental health access for seriously emotionally disturbed youth ages 3–18 in Cambridge, Somerville, Malden, Everett, and Medford through integrated primary care screening and mobile crisis teams. CHA also held congressionally directed construction grants from the Healthcare Systems Bureau (September 2022 through August 2025) for inpatient behavioral health expansion, adding 64–66 beds across two hospital campuses—42 child and adolescent beds with specialized neuro-developmental care at the Somerville campus and 22–24 adult beds at the Cambridge Hospital campus. Additionally, CHA received an Office of Minority Health grant beginning September 2024 for a community health worker program targeting hypertension control among Black, Haitian-Creole-speaking, and Latinx adults in its service area.

CHA's subrecipient role spans research and service implementation on federally funded awards administered by Harvard Medical School, McLean Hospital, Michigan State University, Wake Forest University Health Sciences, Worcester Polytechnic Institute, the General Hospital Corporation, Brigham and Women's Hospital, Boston University, Boston Medical Center, Brandeis University, and Massachusetts state agencies. Subrecipient work includes neuroscience and clinical research—functional MRI studies of migraine and interoceptive awareness (National Institute of Neurological Disorders and Stroke), neural mechanisms of critical self-judgment (National Institute of Mental Health), and predictive algorithms for suicide risk in electronic health records (collaborative with Harvard and Mass General Brigham)—as well as operational roles in multisite clinical trials on first-episode psychosis care, treatment-resistant depression, and mindfulness-based stress reduction for migraine management. CHA's Center for Mindfulness and Compassion has provided MBSR teacher training and fidelity monitoring across multiple NIH-funded studies through Wake Forest and Worcester Polytechnic Institute.

Federal agency concentration sits with health and research funders. The top five customer agencies account for 54% of recent awards and include the Federal Emergency Management Agency (27 awards), the National Institute of Mental Health (20 awards), the National Institutes of Health broadly (15 awards), the Substance Abuse and Mental Health Services Administration (12 awards), and the Department of Homeland Security Chief Procurement Officer (11 awards, $157 thousand combined potential value). The combined potential value across all 157 awards is $182 thousand, though this figure masks substantial federal obligations—$207 million obligated to date substantially exceeds the potential value marker, indicating mature, ongoing grant programs. Award volume has grown from eight in 2022 to 33 in 2024, with 24 awards in 2025 and four in 2026 (through June). Across the recent portfolio, 45% of awards are prime grants and 55% are subrecipient roles, positioning CHA as a significant research and clinical services site within the Harvard and Boston area academic medical network rather than as a primary contract or grant administrator.

SCI data capture minimal federal service contracting activity—two subcontractor records spanning FY2022 and FY2024 with no FTE attribution—reflecting CHA's core identity as a clinical healthcare delivery organization and research institution rather than a federal services contractor. The organization's federal relationship is driven by grant funding for clinical research, behavioral health infrastructure, and community health worker deployment aligned with its mission as a public safety-net hospital system serving Cambridge, Massachusetts and the greater Boston region.